SER
Serina Therapeutics Inc
2.30$
+2.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +198.8% | +10.8% | -30.3% | -47.3% | -19.6% | +2.8% | +176.7% | -25.0% | +3.4% | |
| – | +1,003.6% | +3.4% | -48.4% | -43.7% | -2.1% | +9.8% | +210.6% | -25.5% | +7.1% | |
| – | +2,747.5% | -9.1% | -64.9% | -77.6% | +10.8% | +10.4% | +1,081.2% | -51.8% | -16.8% | |
| – | +2,747.5% | -9.1% | -64.9% | -77.6% | +10.8% | +10.4% | +1,081.2% | -51.8% | -16.8% | |
| – | -65.3% | +22.4% | +177.1% | -10.2% | -92.3% | -84.0% | +1,325.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -19.7% | |
| – | – | – | – | -26.0% | -45.4% | -15.2% | -17.8% | – | – | |
| – | -94.9% | +86.0% | +97.7% | +93.2% | +61.2% | +36.8% | +100.7% | -84.9% | +12.4% | |
| – | -94.9% | +86.0% | +35.1% | +62.5% | +67.4% | +12.4% | -86.0% | +67.4% | +50.6% | |
| – | – | – | – | +459.8% | +198.0% | +7.1% | -52.0% | -94.7% | -100.0% | |
| – | -71.3% | +100.0% | +180.0% | +81.2% | -74.6% | +194.3% | +2.1% | +28.3% | +159.5% | |
| – | – | – | – | – | – | – | +84.5% | -100.0% | – | |
| – | – | +2.3% | -70.2% | -330.7% | – | – | – | – | -105.8% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -2.6% | +6.8% | +1.1% | +0.6% | +0.2% | +679.9% | -12.5% | +38.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.